Extra-label use of nonsteroidal anti-inflammatory drugs in cats is thus contraindicated and remains a risk, especially in circumstances where there may be concomitant dehydration, hypotension and hepatic competition for metabolism of barbiturate or other compounds, thus slowing the process in both.